+

USPP36307P3 - Cannabis plant named ‘21AF0716’ - Google Patents

Cannabis plant named ‘21AF0716’ Download PDF

Info

Publication number
USPP36307P3
USPP36307P3 US18/445,188 US202318445188V USPP36307P3 US PP36307 P3 USPP36307 P3 US PP36307P3 US 202318445188 V US202318445188 V US 202318445188V US PP36307 P3 USPP36307 P3 US PP36307P3
Authority
US
United States
Prior art keywords
variety
plants
new
cannabis
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US18/445,188
Other versions
US20240008379P1 (en
Inventor
Caitlin Watt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curaleaf Dh Inc
Original Assignee
Curaleaf Dh Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curaleaf Dh Inc filed Critical Curaleaf Dh Inc
Priority to US18/445,188 priority Critical patent/USPP36307P3/en
Assigned to CURALEAF DH, INC. reassignment CURALEAF DH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CURALEAF, INC.
Assigned to CURALEAF DH, INC. reassignment CURALEAF DH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CURALEAF, INC.
Publication of US20240008379P1 publication Critical patent/US20240008379P1/en
Assigned to CURALEAF DH, INC. reassignment CURALEAF DH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Grace Executive Services, Inc.
Assigned to Grace Executive Services, Inc. reassignment Grace Executive Services, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Watt, Caitlin
Application granted granted Critical
Publication of USPP36307P3 publication Critical patent/USPP36307P3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/28Cannabaceae, e.g. cannabis

Definitions

  • the new Cannabis plant claimed is of the variety denominated ‘21AF0716’.
  • the present invention relates to a new and distinct annual variety of C. sativa , which has been given the variety denomination of ‘21AF0716’.
  • ‘21AF0716’ is intended for use as a plant both commercially as well as for home growers, including as part of a breeding program to develop improved Cannabis varieties.
  • the genus Cannabis has been in use by humans for millennia, due to the multiplicity of its benefits to humans, including the considerable value and utility of its fiber, the nutritional value of its seeds, and the medicinal value of its floral parts and products made from them.
  • the genus is under intense legal commercialization in the United States as industrial hemp for a variety of purposes including biodegradable plastics and building materials, clothing, paper, food, fuel, and medicines.
  • Cannabidiol (CBD) extracted from Cannabis is widely used in over-the-counter medicines and topical treatments and is also the active ingredient in the FDA-approved drug Epidiolex®.
  • CBD is just one of at least dozens—perhaps hundreds—of cannabinoids endogenous to Cannabis , tetrahydrocannabinol (THC) being the other cannabinoid that is most well-known.
  • THC tetrahydrocannabinol
  • the cannabinoids as a group interact with the human endocannabinoid receptors, which are distributed in the brain and throughout the body.
  • ECS endocannabinoid system
  • Non-hemp forms of Cannabis frequently referred to as marijuana, have been legalized for medicinal use in many states and for recreational use (sometimes called “adult use”) in a growing number of states. It is expected that the wave of legalization will continue to the point of some form of federal legalization or decriminalization.
  • marijuana products are available to users for purchase in specialized “dispensaries” that offer dried flower, edibles, tinctures, extracts, and the like.
  • a unique or unusual chemical profile, or chemotype is attractive not only for flower sales but also for use in the preparation of extracts and/or isolates and for the manufacture of a variety of products that possess characteristics of the chemotype.
  • the present invention relates to a new and distinct annual variety of C. sativa , which has been given the variety denomination of ‘21AF0716’.
  • the new C. sativa variety is a selection resulting from a sexual cross of C. sativa plants in San Mateo County, California, in September 2021, involving a seed parent known as ‘Gelato 33’ (unpatented) and a pollen parent known as ‘Purple Punch’ (unpatented).
  • Selection criteria were high yield, dense flowers, and resistance to powdery mildew under greenhouse conditions.
  • Plants of the new variety differ from plants of the seed parent ‘Gelato 33’ primarily in node spacing between inflorescences, increased inflorescence size, inflorescence density, yield as total weight per plant, and floral aroma.
  • Inflorescence density relates to individual flower parts being closer together in dense flowers, leading to a firmer tactile response. Dense strains resist the pressure of hand pinching rather than breaking apart like a less dense strain. Additionally, denser strains handle machine trimming better than a less dense flower.
  • Plants of the new variety differ from plants of the pollen parent ‘Purple Punch’ in increased continued growth under flowering light, increased inflorescence size, yield as total weight per plant, and floral aroma.
  • the variety expresses increased resistance to powdery mildew, higher total yield, and larger inflorescences than either parent. It exhibits continued growth under flowering light and dark purple coloration on the inflorescences similar to the seed parent and exhibits the inflorescence density and resistance to production of stress-induced male flowers of the pollen parent.
  • the new variety differs from its parents in that it has a higher growth rate and higher yields during winter production, with an intense purpling of flowers.
  • FIG. 1 is a photograph of the new variety ‘21AF0716’, demonstrating the finished flower on a row of mature plants at 8 weeks after induction of flowering.
  • FIG. 2 is a photograph of the mature flowers of the new variety ‘21AF0716’ at 8 weeks after induction of flowering.
  • FIG. 3 is a photograph of young flowers of new variety ‘21AF0716’ under greenhouse conditions at 3 weeks after induction of flowering.
  • FIG. 4 is a photograph of young flowers of the new variety ‘21AF0716’ under greenhouse conditions at 6 weeks after induction of flowering.
  • FIG. 5 is a photograph of the immature plant of the new variety ‘21AF0716’ at 3 months of growth under vegetative conditions.
  • ‘21AF0716’ can include a cannabinoid profile as set forth in Table 1.
  • Chemotypic characteristics of the new variety are variable based upon cultivation conditions, as is typical of Cannabis plants. Accordingly, while chemotypic information provided herein is representative of performance of the new varieties under a particular set of cultivation conditions, it is not limiting on other chemotypic profiles obtainable under a different set of cultivation conditions. Thus, the values set forth in Table 1 do not reflect the only possible range of outcomes that can be obtained from plants of the new variety. These values are merely exemplary of observed values (middle column) and predicted normal variations from the observed values.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

The unique annual herbaceous Cannabis plant variety ‘21AF0716’ is provided. The variety can be distinguished by its outstanding features of increased resistance to powdery mildow, higher total yield, and larger inflorescences compared to its parents.

Description

Latin name of the genus and species:
Genus—Cannabis.
Species—sativa.
Variety denomination: The new Cannabis plant claimed is of the variety denominated ‘21AF0716’.
BACKGROUND OF THE INVENTION Field of the Invention
The present invention relates to a new and distinct annual variety of C. sativa, which has been given the variety denomination of ‘21AF0716’. ‘21AF0716’ is intended for use as a plant both commercially as well as for home growers, including as part of a breeding program to develop improved Cannabis varieties.
Background of the Related Art
The genus Cannabis has been in use by humans for millennia, due to the multiplicity of its benefits to humans, including the considerable value and utility of its fiber, the nutritional value of its seeds, and the medicinal value of its floral parts and products made from them. Currently the genus is under intense legal commercialization in the United States as industrial hemp for a variety of purposes including biodegradable plastics and building materials, clothing, paper, food, fuel, and medicines.
Cannabidiol (CBD) extracted from Cannabis is widely used in over-the-counter medicines and topical treatments and is also the active ingredient in the FDA-approved drug Epidiolex®. CBD is just one of at least dozens—perhaps hundreds—of cannabinoids endogenous to Cannabis, tetrahydrocannabinol (THC) being the other cannabinoid that is most well-known. The cannabinoids as a group interact with the human endocannabinoid receptors, which are distributed in the brain and throughout the body. The study of the endocannabinoid system (ECS) in humans and other mammals is an area of increasing interest and holds tremendous promise for the future of medicine. See, e.g., Russo (2019). Cannabis and Pain, Pain Medicine, 20(10): 1;20(11):2083-2085; and Russo (2016). Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes, Cannabis Cannabinoid Res. 1(1): 154-165.
Non-hemp forms of Cannabis, frequently referred to as marijuana, have been legalized for medicinal use in many states and for recreational use (sometimes called “adult use”) in a growing number of states. It is expected that the wave of legalization will continue to the point of some form of federal legalization or decriminalization.
Typically, marijuana products are available to users for purchase in specialized “dispensaries” that offer dried flower, edibles, tinctures, extracts, and the like. In some cases, a unique or unusual chemical profile, or chemotype, is attractive not only for flower sales but also for use in the preparation of extracts and/or isolates and for the manufacture of a variety of products that possess characteristics of the chemotype.
SUMMARY OF THE INVENTION
The present invention relates to a new and distinct annual variety of C. sativa, which has been given the variety denomination of ‘21AF0716’.
The new C. sativa variety is a selection resulting from a sexual cross of C. sativa plants in San Mateo County, California, in September 2021, involving a seed parent known as ‘Gelato 33’ (unpatented) and a pollen parent known as ‘Purple Punch’ (unpatented).
Selection criteria were high yield, dense flowers, and resistance to powdery mildew under greenhouse conditions.
The selection was subsequently evaluated for a number of years in California.
Asexual reproduction of the new variety by cutting propagation since 2021 in San Mateo County, California has demonstrated that the new variety reproduces true to type with all of the morphological characteristics, as herein described, firmly fixed and retained through successive generations of such asexual propagation.
Certain characteristics of the new variety have been repeatedly observed and can be used to distinguish ‘21AF0716’ as a new and distinct variety of C. sativa plant. Plants of the new variety differ from plants of the seed parent ‘Gelato 33’ primarily in node spacing between inflorescences, increased inflorescence size, inflorescence density, yield as total weight per plant, and floral aroma. Inflorescence density relates to individual flower parts being closer together in dense flowers, leading to a firmer tactile response. Dense strains resist the pressure of hand pinching rather than breaking apart like a less dense strain. Additionally, denser strains handle machine trimming better than a less dense flower. Plants of the new variety differ from plants of the pollen parent ‘Purple Punch’ in increased continued growth under flowering light, increased inflorescence size, yield as total weight per plant, and floral aroma. The variety expresses increased resistance to powdery mildew, higher total yield, and larger inflorescences than either parent. It exhibits continued growth under flowering light and dark purple coloration on the inflorescences similar to the seed parent and exhibits the inflorescence density and resistance to production of stress-induced male flowers of the pollen parent. The new variety differs from its parents in that it has a higher growth rate and higher yields during winter production, with an intense purpling of flowers.
Certain characteristics of the new variety have been repeatedly observed and can be used to distinguish ‘21AF0716’ as a new and distinct variety of C. sativa plant. Plants of the new variety differ from plants of the commercial variety ‘Eureka’ (unpatented) primarily in color. ‘21AF0716’ contains a significant purple coloring on the plant, while ‘Eureka’ lacks purple coloring.
BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying photographic illustrations show the typical appearance of the new variety ‘21AF0716’. The colors are as nearly true as is reasonably possible in a color representation of this type. Colors in the photographs may differ slightly from the color values cited in the detailed botanical description which accurately describes the colors of the new plant. Induction of flowering occurs in plants that are in vegetative growth, either by natural changes in daylength or by induction of flowering through changes in lighting of the plants. Ages provided herein are counted from the beginning of the induction of flowering and are typically reported in weeks. Because the duration of vegetative growth can be variable and can be based upon desired plant size, absolute age of plants is less relevant and can be, itself, quite variable.
FIG. 1 is a photograph of the new variety ‘21AF0716’, demonstrating the finished flower on a row of mature plants at 8 weeks after induction of flowering.
FIG. 2 is a photograph of the mature flowers of the new variety ‘21AF0716’ at 8 weeks after induction of flowering.
FIG. 3 is a photograph of young flowers of new variety ‘21AF0716’ under greenhouse conditions at 3 weeks after induction of flowering.
FIG. 4 is a photograph of young flowers of the new variety ‘21AF0716’ under greenhouse conditions at 6 weeks after induction of flowering.
FIG. 5 is a photograph of the immature plant of the new variety ‘21AF0716’ at 3 months of growth under vegetative conditions.
DETAILED BOTANICAL DESCRIPTION
The following detailed description sets forth the distinctive characteristics of ‘21AF0716’. The datum which defines these characteristics was collected from asexual reproductions of the original selection. Dimensions, sizes, colors, and other characteristics are approximations and averages set forth as accurately as possible. The plant history was taken on mother plants approximately 3 months old, and the descriptions relate to plants grown in Half Moon Bay, California. Color notations are in reference to the standard hexadecimal (HEX) color code.
  • Type: Herbaceous annual.
  • Classification:
      • a. Family.—Cannabaceae.
      • b. Genus.—Cannabis.
      • c. Species.—sativa.
      • d. Common name.—Marijuana.
  • Parentage: ‘Gelato 33’ x ‘Purple Punch’.
PLANT
  • General:
      • a. Parentage.—i. Female parent — ‘Gelato 33’. ii. Reversed Female parent — ‘Purple Punch’.
      • b. Growth habit.—Medium growth habit with strong branches and compact structure.
      • c. Hardiness.—USDA Zone 2 and higher.
      • d. Average height.—56 inches.
      • e. Average spread.—28 inches.
      • f. Productivity.—94 g of dry weight per 5-gallon potted plant at 3 weeks veg and 8 weeks flower time.
      • g. Disease resistance/susceptibility.—Low susceptibility to bud rot and powdery mildew under standard growing conditions. i. Powdery Mildew — Golovinomyces ambrosiae.
      • h. Fragrance.—Cake, cookie and gassy aroma.
      • i. Proportion of hermaphrodite plants.—Low.
      • j. Proportion of female plants.—Female plants are agronomically significant and seeds are feminized.
      • k. Type of inflorescence.—High branched compound racemose.
      • l. Photoperiodicity.—Short day photoperiod sensitive.
STEM/CENTRAL STALK
  • General:
      • a. Average diameter of stem.—1 inch.
      • b. Average length of stem.—48 inches.
      • c. Shape.—Tubular.
      • d. Depth of grooves.—Shallow.
      • e. Pith in cross section.—Medium.
      • f. Trichome type.—Few trichomes.
      • g. Color.—Stems are green (#49C369) with reddish/purple stripes (#a33650).
LEAF
  • General:
      • a. Leaf arrangement.—Alternate.
      • b. Leaf shape.—Palmately Compound.
      • c. Leaf margins.—Serrate.
      • d. Leaf apex shape.—Acuminate.
      • e. Leaf base shape.—Attenuate.
      • f. Number of leaflets per leaf.—5-7.
      • g. Trichome type (top surface).—On sugar leaves near inflorescences numerous cystolithic hair, bulbous, capitate sessile or capitate stalked.
      • h. Texture of top and bottom surfaces.—Pubescent leaves.
      • i. Venation type.—Pinate.
      • j. Length.—6 in.
      • k. Width.—1.5 in.
      • l. Color of upper surface.—Dark green #007848.
      • m. Color of lower surface.—Bright green #74C365.
PETIOLE
  • General:
      • a. Surface texture.—Pubescent.
      • b. Anthocyanin intensity.—Intense at end of growing season.
      • c. Color.—Stems are green (#49C369) with reddish/purple stripes (#a33650).
      • d. Length.—⅛ of an inch at 3 weeks of vegetation and having been topped.
      • e. Diameter.—5-15 mm.
INFLORESCENCE
  • General:
      • a. Natural flowering season.—Summer.
      • b. Color.—Purple (#A020F0). i. Trichome type — Numerous cystolithic hair, bulbous, capitate sessile or capitate stalked, trichomes start clear turning to amber over time.
      • c. Stigma color.—White (##FFFAF0).
      • d. Bract color.—#32CD32, turns purple at the latter part of flowering stage.
      • e. Shape.—Oval. Flower spirals around the stalks.
      • f. Length.—75 mm.
      • g. Width.—38 mm.
      • h. Internodal spacing—78.2 mm.
‘21AF0716’ can include a cannabinoid profile as set forth in Table 1. Chemotypic characteristics of the new variety are variable based upon cultivation conditions, as is typical of Cannabis plants. Accordingly, while chemotypic information provided herein is representative of performance of the new varieties under a particular set of cultivation conditions, it is not limiting on other chemotypic profiles obtainable under a different set of cultivation conditions. Thus, the values set forth in Table 1 do not reflect the only possible range of outcomes that can be obtained from plants of the new variety. These values are merely exemplary of observed values (middle column) and predicted normal variations from the observed values.
TABLE 1
Exemplary Profiles of Key Cannabinoids.
Cannabinoid Percent Percent Percent Percent Percent
THCa 17.63625 18.812 23.515 28.218 29.39375
Delta 9 THC  0.472425  0.50392  0.6299  0.75588  0.787375
CBGa  0.4206  0.44864  0.5608  0.67296  0.701
CBCa  0.141375  0.1508  0.1885  0.2262  0.235625
THCVa  0.054075  0.05768  0.0721  0.08652  0.090125
CBDa  0.03255  0.03472  0.0434  0.05208  0.05425
CBG  0.031725  0.03384  0.0423  0.05076  0.052875
Total THC 15.939375 17.002 21.2525 25.503 26.56563
Total CBD  0.028575  0.03048  0.0381  0.04572  0.047625
Total 11.0266 17.64256 22.0532 26.46384 27.5665
Cannabinoid
* Total THC = (THCA * 0.877) + THC (i.e., delta 9 THC) + delta 8 THC
** Total CBD = CBD + (CBDa * 0.877)
*** Total Cannabinoids = Total THC + Total CBD +Total CBG + Total THCV + Total CBC +Total CBDV + Δ8THC + CBL + CBN]

Claims (1)

What is claimed is:
1. A new and distinct variety of Cannabis plant named ‘21AF0716’, as illustrated and described herein.
US18/445,188 2022-05-20 2023-05-16 Cannabis plant named ‘21AF0716’ Active USPP36307P3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US18/445,188 USPP36307P3 (en) 2022-05-20 2023-05-16 Cannabis plant named ‘21AF0716’

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263365117P 2022-05-20 2022-05-20
US18/445,188 USPP36307P3 (en) 2022-05-20 2023-05-16 Cannabis plant named ‘21AF0716’

Publications (2)

Publication Number Publication Date
US20240008379P1 US20240008379P1 (en) 2024-01-04
USPP36307P3 true USPP36307P3 (en) 2024-12-10

Family

ID=89433033

Family Applications (1)

Application Number Title Priority Date Filing Date
US18/445,188 Active USPP36307P3 (en) 2022-05-20 2023-05-16 Cannabis plant named ‘21AF0716’

Country Status (1)

Country Link
US (1) USPP36307P3 (en)

Also Published As

Publication number Publication date
US20240008379P1 (en) 2024-01-04

Similar Documents

Publication Publication Date Title
USPP31707P3 (en) Cannabis plant named ‘GRAPE LOLIPOP’
USPP27475P2 (en) Cannabis plant named ‘Ecuadorian Sativa’
US20160073568P1 (en) Cannabis plant named 'MIDNIGHT'
US20200323163A1 (en) Cannabis plant named 'v2'
USPP36307P3 (en) Cannabis plant named ‘21AF0716’
USPP35171P2 (en) Cannabis plant named ‘SW0’
US20220159921A1 (en) Cannabis plant named 'drg3'
USPP33162P3 (en) Hemp plant named ‘Eighty Eight’
USPP33182P3 (en) Hemp plant named ‘Painted Lady’
US20220007610A1 (en) Cannabis plant named 'drg1'
USPP33332P3 (en) Cannabis plant named ‘HAPPY PINEAPPLE’
USPP36496P3 (en) Cannabis plant named ‘ow-1’
US20200315118A1 (en) CANNABIS PLANT NAMED 'FS-tp2'
US20220256799A1 (en) Cannabis plant named 'lpa004'
USPP35836P3 (en) Cannabis plant named ‘OT-1’
US20230329130P1 (en) Cannabis Plant Named 'DRG2'
USPP34829P3 (en) Cannabis plant named BAGZXCD6-PA#2
US20240306521P1 (en) Cannabis plant named 'rsbt1brm'
US20220007611A1 (en) Cannabis plant named 'drg2'
US20220330466P1 (en) Cannabis plant named 'vb252x'
US20230337561P1 (en) Cannabis plant named 'drg1'
USPP35873P2 (en) Cannabis plant named ‘D1118’
USPP35083P3 (en) Cannabis plant named ‘Red KROSS02-BK’
USPP12828P2 (en) Fig tree named ‘Violetta’
US20210219512A1 (en) Cannabis plant named 'ot-1'

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

AS Assignment

Owner name: CURALEAF DH, INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CURALEAF, INC.;REEL/FRAME:065949/0493

Effective date: 20231218

Owner name: CURALEAF DH, INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CURALEAF, INC.;REEL/FRAME:065949/0508

Effective date: 20231218

AS Assignment

Owner name: CURALEAF DH, INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GRACE EXECUTIVE SERVICES, INC.;REEL/FRAME:066257/0856

Effective date: 20240117

AS Assignment

Owner name: GRACE EXECUTIVE SERVICES, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WATT, CAITLIN;REEL/FRAME:067466/0023

Effective date: 20220906

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载